Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.
3.

Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors.

Puolakkainen M, Lee A, Nosaka T, Fukushi H, Kuo CC, Campbell LA.

Microb Pathog. 2008 May;44(5):410-6. Epub 2007 Nov 23.

4.
5.

Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells.

Campbell LA, Puolakkainen M, Lee A, Rosenfeld ME, Garrigues HJ, Kuo CC.

Microbes Infect. 2012 Jan;14(1):43-9. doi: 10.1016/j.micinf.2011.08.003. Epub 2011 Aug 30.

6.

Inhibitory effect of heparan sulfate-like glycosaminoglycans on the infectivity of Chlamydia pneumoniae in HL cells varies between strains.

Yan Y, Silvennoinen-Kassinen S, Leinonen M, Saikku P.

Microbes Infect. 2006 Mar;8(3):866-72. Epub 2006 Jan 17.

PMID:
16500132
7.

Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis.

Swanson AF, Ezekowitz RA, Lee A, Kuo CC.

Infect Immun. 1998 Apr;66(4):1607-12.

8.

Naturally occurring amino acids differentially influence the development of Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.

Al-Younes HM, Gussmann J, Braun PR, Brinkmann V, Meyer TF.

J Med Microbiol. 2006 Jul;55(Pt 7):879-86.

PMID:
16772415
9.

Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae.

Tapia O, Slepenkin A, Sevrioukov E, Hamor K, de la Maza LM, Peterson EM.

Clin Diagn Lab Immunol. 2002 May;9(3):562-7.

10.

In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.

Roblin PM, Kohlhoff SA, Parker C, Hammerschlag MR.

Antimicrob Agents Chemother. 2010 Mar;54(3):1358-9. doi: 10.1128/AAC.01343-09. Epub 2009 Dec 28.

11.

Treatment of Chlamydial infections: 2014 update.

Kohlhoff SA, Hammerschlag MR.

Expert Opin Pharmacother. 2015 Feb;16(2):205-12. doi: 10.1517/14656566.2015.999041. Review.

PMID:
25579069
12.

Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells.

Molestina RE, Miller RD, Lentsch AB, Ramirez JA, Summersgill JT.

Infect Immun. 2000 Jul;68(7):4282-8.

13.

Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma.

Bellmann-Weiler R, Martinz V, Kurz K, Engl S, Feistritzer C, Fuchs D, Rupp J, Paldanius M, Weiss G.

Immunobiology. 2010 Sep-Oct;215(9-10):842-8. doi: 10.1016/j.imbio.2010.05.021. Epub 2010 Jun 4.

PMID:
20646782
14.

[Effector proteins of Clamidia].

Kariagina AS, Alekseevskiĭ AV, Spirin SA, Zigangirova NA, Gintsburg AL.

Mol Biol (Mosk). 2009 Nov-Dec;43(6):963-83. Review. Russian.

PMID:
20088373
15.

Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

Read TD, Brunham RC, Shen C, Gill SR, Heidelberg JF, White O, Hickey EK, Peterson J, Utterback T, Berry K, Bass S, Linher K, Weidman J, Khouri H, Craven B, Bowman C, Dodson R, Gwinn M, Nelson W, DeBoy R, Kolonay J, McClarty G, Salzberg SL, Eisen J, Fraser CM.

Nucleic Acids Res. 2000 Mar 15;28(6):1397-406.

16.

Low iron availability modulates the course of Chlamydia pneumoniae infection.

Al-Younes HM, Rudel T, Brinkmann V, Szczepek AJ, Meyer TF.

Cell Microbiol. 2001 Jun;3(6):427-37.

PMID:
11422085
17.

[The prevalence of anti-Chlamydia trachomatis and anti-Chlamydia pneumoniae antibodies in Brazzaville].

Biendo M, Lefebvre JF, Fuentes V, Orfila J.

Bull Soc Pathol Exot. 1994;87(2):85-8. French.

PMID:
8061533
18.
19.

[Role of Chlamydia trachomatis and Chlamydophila pneumoniae in damage of eye posterior segment structures].

Chepur SV, Boĭko ÉV, Pozniak AL, Nuralova IV, Mal'tsev DS, Suetov AA.

Zh Mikrobiol Epidemiol Immunobiol. 2012 May-Jun;(3):79-82. Russian.

PMID:
22830280
20.

In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.

Roblin PM, Hammerschlag MR.

Int J Antimicrob Agents. 2000 Sep;16(1):61-3.

PMID:
11185415

Supplemental Content

Support Center